4
Changes in Ownership
ARS Pharmaceuticals, Inc. Filed Acc 0001415889-24-023709
PRESIDENT AND CEO sold 100,000 shares at an average $12.93 ($1,293,205)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lowenthal Richard E PRESIDENT AND CEO | 2024-09-17 | Sale 10b5-1 | −50,000 | $12.93 | $646,525 | 1,447,447 | I |
| Lowenthal Richard E PRESIDENT AND CEO | 2024-09-17 | Sale 10b5-1 | −50,000 | $12.93 | $646,680 | 1,398,499 | I |
| Open-market sales · 100,000 sh · avg $12.93 · $1,293,205 | |||||||
Loading xslF345X05/form4-09192024_080917.xml…